This website is in the process of being updated. Our full portfolio of products will be available on this page in due course. In the meantime, for safety and patient information relating to products not currently listed, please refer to the http://www.medicines.ie/.
Showing refined by:
-
Anoro▼ Ellipta (umeclidinium/vilanterol inhalation powder)
Anoro▼ Ellipta (umeclidinium/vilanterol) information & resources to support healthcare professionals registered in Ireland in their daily practice. -
Avamys
Avamys Nasal Spray information & resources to support healthcare professionals registered in Ireland in their daily practice -
Bexsero (meningococcal group B Vaccine (rDNA, component, adsorbed))
Bexsero (Meningococcal group B Vaccine (rDNA, component, adsorbed)) information for members of the UK public -
Dovato (dolutegravir/lamivudine)
Content is provided on this website for products with an Ireland product license. In some cases, content may be provided relating to products that have mutual recognition or national license, which has been created for Irish audiences. -
Ellipta inhaler (device information)
A product overview of the Ellipta device for member of the Irish public -
Incruse▼ Ellipta (umeclidinium bromide)
Incruse▼ Ellipta (umeclidinium bromide) information about Incruse for members of the public in Ireland -
Menitorix (haemophilus type b & meningococcal group C conjugate vaccine)
Information on Menitorix for Members of the Public in Ireland -
Nucala (mepolizumab)
Nucala information for Ireland members of the public -
Relvar Ellipta (fluticasone furoate/vilanterol)
The official Relvar (fluticasone furoate/vilanterol) product overview for members of the public in the Republic of Ireland -
Rotarix (rotavirus vaccine, live)
Information on Rotarix for Members of the Public in Ireland -
Seretide (salmeterol xinafoate/fluticasone propionate) | GSK Pharma Ireland | Public Site |
Seretide (salmeterol xinafoate /fluticasone propionate) patient information for members of the public in the Republic of Ireland -
Volibris (ambrisentan)
Links to the Volibris Summary of Product Characteristics (SPC), Patient Information Leaflet (PIL) and educational materials for patients and partners
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
There are no results matching your refine settings
Show more
Other products
Content is provided on this website for products with an Ireland product licence. In some cases, content may be provided relating to products that have mutual recognition or national licence, which has been created for Irish audiences.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to the HPRA Pharmacovigilance, Earlsfort Terrace, Dublin 2.
Tel: +353 1 6764971; Fax: +353 1 6762517.
Website: www.hpra.ie; e-mail:medsafety@hpra.ie.
By reporting side effects, you can help provide more information on the safety of this medicine.
Trademarks are owned by or licensed to the GSK group of companies.
▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.
GOL. Last updated July 2020. NP-IE-UCV-WCNT-190010
